New drug TAK-188 aims to unleash immune system against Hard-to-Treat tumors
NCT ID NCT07205718
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This study tests a new medicine called TAK-188 in adults with advanced solid tumors that have not improved with standard treatments. TAK-188 targets and removes certain cells inside tumors that weaken the immune system, potentially allowing the body to better fight the cancer. The trial will check safety, tolerability, and how well the drug works over up to one year of treatment, with follow-up for another year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Barbara Ann Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
-
Florida Cancer Specialists - Lake Nona
RECRUITINGOrlando, Florida, 32827, United States
-
Fox Chase Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19111-2497, United States
-
Johns Hopkins
RECRUITINGBaltimore, Maryland, 21231, United States
Contact Email: •••••@•••••
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030-4000, United States
-
NEXT Dallas
RECRUITINGIrving, Texas, 75039, United States
-
NEXT Virginia
RECRUITINGFairfax, Virginia, 22031, United States
-
Providence Cancer Institute, Franz Clinic
RECRUITINGPortland, Oregon, 97213-2933, United States
-
SCRI Oncology
RECRUITINGNashville, Tennessee, 37203, United States
-
START Midwest
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
START San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
UCLA Health-Santa Monica Cancer Care (Cancer Care - Santa Monica)
RECRUITINGSanta Monica, California, 90404, United States
-
University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106-1716, United States
-
Washington University
RECRUITINGSt Louis, Missouri, 63108, United States
-
Yale School of Medicine - Smilow Cancer Hospital - Center for Thoracic Cancers
RECRUITINGNew Haven, Connecticut, 06511, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a dual protein blocker shrink Hard-to-Treat tumors?
- Can a new biologic boost the immune System's fight against advanced tumors?
- Experimental pill SHY-ONC6 takes on Hard-to-Treat cancers
- Experimental pill takes on advanced cancers alongside immunotherapy
- Smart T-Cell engager aims to outsmart tumors in first human test